Here are relevant reports on : sleep-coaching-market
-
Sleep Software Market by Function (Sleep Tracking, Analysis, Disorder Management, Improvement), Indication (Insomnia, Sleep Apnea), Offering (Platforms, Apps (Mobile)), End-user (Providers, Individual), Deployment, Type, & Region - Global Forecast to 2030
The global sleep software market, valued at US$776.2 million in 2023, stood at US$878.9 million in 2024 and is projected to advance at a resilient CAGR of 10.1% from 2024 to 2030, culminating in a forecasted valuation of US$1,569.2 million by the end of the period. The market growth is mainly fueled by increased awareness of sleep health and the rising adoption of wearable technologies and AI-based solutions.
- Published: January 2025
- Price: $ 4950
- TOC Available:
-
Mental Health Apps Market by Platform (Android, iOS), Application (Depression, Meditation, Stress, Trauma), Function (Screening, Consultation, Prescription, Treatment, Monitoring, Coaching), End User (Provider, Patient, Employer) - Global Forecast to 2030
The Mental Health Apps market, valued at US$8.21 billion in 2024, stood at US$9.94 billion in 2025 and is projected to advance at a resilient CAGR of 18.0% from 2025 to 2030, culminating in a forecasted valuation of US$22.73 billion by the end of the period. The mental health apps market is growing rapidly, driven by advancements in digital technologies such as artificial intelligence, data analytics, and mobile health platforms.
- Published: June 2026
- Price: $ 4950
- TOC Available:
-
Sleep Tech Market by Product, Application, End-Use Industry, and Region - Global Forecast to 2030
The market for sleep technology has been developing significantly and is predicted to do so in the upcoming years. The favourable market outlook is influenced by a number of factors, including:
- Published: July 2026
- Price: $ 4950
- TOC Available:
-
U.S. Insomnia Market by Non-Pharmacological Therapy (CBTI, Hypnotherapy), Prescription Sleep Aids (Benzodiazepines, Non-Benzodiazepines (Zaleplon), Orexin Antagonist) & OTC Treatment (Antihistamine, Melatonin, Valerian Root)) - - Global Forecast to 2021
The U.S. insomnia market is categorised into pharmacological treatments and non-pharmacological treatments. The U.S. insomnia pharmacological treatment market is projected to reach USD 4.24 Billion by 2021 from USD 3.38 Billion in 2016, growing at a CAGR of 4.6% from 2016 to 2021. The duration of insomnia can be from a day to years. Based on duration, insomnia is divided into three major categories, namely, transient insomnia (less than a month), short term insomnia (between 1 month and 6 months), and chronic insomnia (more than 6 months).
- Published: January 2017
- Price: $ 4950
- TOC Available:
-
Transcutaneous Monitors Market by Type (Adult Wound Healing, Neonatal Care), Application (Sleep Diagnostics, Respiratory Care, Plastic surgery) & End User (Hospitals, Speciality Clinic, Neonatal Intensive Care, Diagnostic Center) - Global Forecast to 2023
The global transcutaneous monitors market is expected to reach USD 206.9 million by 2023 from USD 154.6 million in 2018, growing at a CAGR of 6.0%. Increasing demand for non-invasive monitoring; rising risk of respiratory diseases; increasing healthcare expenditure in developing economies such as India, China, Brazil; and technological advancement leading to more accuracy are some of the major factors driving the growth of the global transcutaneous monitors market. These driving factors consequence to the rapid adoption of these new devices, thus propelling the market growth.
- Published: July 2026
- Price: $ 4950
- TOC Available:
-
Sleep Apnea Oral Appliances Market by Product (Mandibular Advancement Devices (MAD), Tongue-Retaining Devices (TRD)), Purchase Type (Physician-prescribed), Gender (Male, Female), Age Group, Distribution Channel (Online, Retail) - Global Forecast to 2030
The global sleep apnea oral appliances market, valued at US$0.4B in 2024, is forecasted to grow at a 9.8% CAGR, reaching US$0.5B by 2025 and US$0.8B by 2030.
- Published: May 2025
- Price: $ 4950
- TOC Available:
-
Sleep Apnea Devices Market by Product (Therapeutic (PAP (CPAP, APAP, BPAP), Oral Appliances, Masks), Diagnostic (PSG, Home Sleep Testing, Oximeter)), Age, Gender, End User (Sleep Clinics, Hospitals, Home Care Settings) - Global Forecast to 2032
The global sleep apnea devices market, valued at USD 6.47 billion in 2024, stood at USD 6.93 billion in 2025 and is projected to advance at a resilient CAGR of 10.9% from 2025 to 2032, culminating in a forecasted valuation of USD 11.61 billion by the end of the period. The growth in this market is expected to be driven by a large pool of undiagnosed sleep apnea patients globally, as well as favorable reimbursement and financial aid for sleep apnea devices and therapies.
- Published: June 2025
- Price: $ 4950
- TOC Available:
-
Europe Sleep Apnea Devices Market by Product [Therapeutic {PAP (CPAP, APAP, BPAP), Oral Appliances, Masks}, Diagnostics {PSG, Home Sleep Testing, Oximeter}]; Age, Gender, End User [Sleep Clinics, Hospitals, Home Care Settings] - Forecast to 2031
The Europe Sleep Apnea Devices market, valued at US$1.76 billion in 2025, stood at US$1.88 billion in 2026 and is projected to advance at a resilient CAGR of 7.4% from 2026 to 2031, culminating in a forecasted valuation of US$2.79 billion by the end of the period. Market growth across Europe is driven primarily by the rising prevalence of obstructive sleep apnea and other chronic conditions, such as obesity and CVD.
- Published: June 2026
- Price: $ 8150
- TOC Available:
-
US Sleep Apnea Devices Market by Product [Therapeutic {PAP (CPAP, APAP, BPAP), Oral Appliances, Masks}, Diagnostic {PSG, Home Sleep Testing, Oximeter}], Age, Gender, End User [Sleep Clinics, Hospitals, Home Care Settings] – Forecast to 2031
The US sleep apnea devices market, valued at US$2.90 billion in 2025, stood at US$3.11 billion in 2026 and is projected to advance at a resilient CAGR of 7.8% from 2026 to 2031, culminating in a forecasted valuation of US$4.54 billion by the end of the period. The market's growth can be attributed to the rising prevalence of sleep apnea and other lifestyle-related disorders. Additionally, greater awareness of the health risks associated with sleep apnea is expected to further boost demand for these devices.
- Published: June 2026
- Price: $ 4950
- TOC Available:
-
COVID-19 Impact on Critical Care Device Market by Device (High-Impact Products (Ventilators, Patient Monitors, Infusion Pumps, Hyperbaric Oxygen Therapy Devices and Sleep Apnea Devices) and Low-Impact Products (Anesthesia Machines, Defibrillators and Blood Warmers)) and Region - Global Forecast to 2021
The global critical care devices market size is expected to reach USD 27.29 billion by 2021 from an estimated value of USD 37.97 billion in 2020. The critical care devices market is expected to witness a growth of 44.1% from 2019 to 2020. The prominent players in the global critical care devices market are Becton, Dickinson and Company (US), B. Braun Melsungen AG (Germany), Baxter International Inc. (US), Fresenius Kabi (Germany), Medtronic plc (Ireland), Moog Inc. (US), Smiths Medical (US), and Philips Healthcare (Netherlands), among others
- Published: May 2020
- Price: $ 4950
- TOC Available:
Records 1 to 10 of 50
